Masimo, the medical know-how firm whose lawsuit led to the non permanent gross sales pause of the Apple Watch Sequence 9 and Extremely 2, has sued the US Customs and Border Safety days after Apple launched its redesigned blood oxygen monitoring function. That is simply the newest replace within the prolonged authorized saga between Masimo and Apple, which began when the previous sued the iPhonemaker in 2021, accusing it of infringing on a number of of its light-based blood oxygen monitoring patents. After a court docket sided with Masimo in 2023, Apple was pressured to cease promoting the Watch Sequence 9 and the Extremely 2 within the US for just a few weeks.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
